• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Live Link
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • News
    • Careers

Get started
Sign in
Close

Blog

Mounjaro leads to significantly more weight loss than Ozempic, study suggests

July 8, 2024
In the largest comparative effectiveness study of tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss using real-world data – now published in JAMA Internal Medicine – Truveta Research found that patients with overweight or obesity taking tirzepatide were three times more likely to achieve 15% weight loss than those taking semaglutide.

Real-world data study comparing Mounjaro and Ozempic for weight loss published in JAMA Internal Medicine

July 8, 2024
Recently, researchers published new insights in Diabetes using Truveta Data that explores the use of continuous glucose monitoring (CGM) in patients with type 2 diabetes (T2D) prior to and after initiating GLP-1 medications.

Truveta Data used in new study finds increased use of CGM in patients with type 2 diabetes initiating GLP-1 medications

July 2, 2024
Truveta healthcare AI technology ensures accuracy and explainability while assuring fairness and avoiding bias

Delivering accuracy and explainability for AI

July 1, 2024
Truveta announced advanced regulatory and audit capabilities to support its customers for real-world evidence (RWE) submissions to the Food and Drug Administration (FDA) and other global regulatory authority decisions. Truveta offers the most complete, timely, and clean regulatory-grade electronic health record (EHR) data from more than 100 million patients across 30 US health systems, empowering researchers to study all diseases, drugs, and devices.

Truveta supports regulatory submissions to the FDA and global regulatory authorities

June 17, 2024
migraine research and migraine treatment from EHR real world data

Migraine research unveiled: Insights from real-world EHR data and notes

June 14, 2024
PSA testing, prostate-specific antigen testing, EHR data, prostate cancer screening

Trends in PSA testing to screen for prostate-related conditions, including cancer

June 10, 2024
AI large language model

Generating data gravity

May 30, 2024
  • « Previous
  • 1
  • …
  • 25
  • 26
  • 27
  • …
  • 44
  • Next »

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Research

Resources

Blog

News

Careers

Privacy notice

Contact us

© Truveta 2026

Our website uses cookies to ensure you have the best experience.